NCT07408089
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07408089
Title Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer (KOMODO-1)
Acronym KOMODO-1
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Boundless Bio, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
NEXT Oncology RECRUITING Austin Texas 78758 United States Details
NEXT Oncology RECRUITING Houston Texas 77054 United States Details
NEXT Oncology RECRUITING San Antonio Texas 78229 United States Details
The START Center for Cancer Care RECRUITING San Antonio Texas 78229 United States Details
NEXT Oncology RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field